Yep...I saw that this morning on Squawk Box....Joe Kernen and Becky Quick did a story on the tremendous Bio Tech Boom in the Boston area...
specifically around MIT. ...Robert Langer mentioned specifically.. ...he is the man!
Good things coming. Don't be on the sidelines on this one people.
Almost all of BKTR longs here have no problem with the clown's absurd valuation. If Kennedy claims NKTR is worth 10 cents, he will get a lot of angry posts from them. To make a long story short, they are strongly opinionated about NKTR stock and have completely lost objectivity, which is a critical mistake in investing. You are known by the company you keep. You are like the crazy clown and are losing money almost everyday, which you want to see in order to buy more shares of NKTR at cheaper prices. You will get what you wish for.
Sentiment: Strong Sell
Cabrera (Insider) just purchased 8000 shares of INO! Lots of people jumping to conclusions here. Plll costs money and we knew this dilution was coming!
I meant to also indicate buy oil & gas stocks that are not heavily dependent on production from the Middle East, Africa, or South America.
You may be right. But the production revenue in Q3 is almost nothing.
Assumig $19.5 component cost for each order. We only get $2.69 for each unit. That is too small.
I was incorrect in my response to damjana when in tried to point out the insider buying. I said the purchases were actually options but they were actually SHARES given to management that has created negative value for all you longs. 432 thousand shares given away for pitiful performance. They are crooks! Drop the R what do you have ...... Cook. Now you will get the selling to "cover taxes" Given their over paid salary and bonus' you would think they could afford to pony up for taxes but nooooo let let the shareholders pay that too. Wait till you see the option grants and bonuses. I have never seen anything like this a company that grows at 10% when the sector grows at 50% (based on Billion dollar numbers) Paying incompetent management like the do. Need to clean out the whole C suite
Go right on ahead.
Kent Wu is probably glad to have some company.
There is lots and lots of meat on the bones of DVAX to chew off.
Short that bad boy down to $10.00 and you'll do well.
No products, no revenues, no suitors, minus a partner (GSK), and it ALL hangs on one "candidate", Heplisav; and Hepliav hasn't gone anywhere CLOSE to producthood since before 2008. AND they are apparently being investigated by a lawfirm, AGAIN.
Outboard Jack said that he wanted to play with some fire; so go ahead you shorts and give the man what he's asking for....... :-)
Yes and Biib should be added into this discussion. But the market was very interested for a day or so in the BIIB results. Now they are committing 2.5b to the development they say. We will see what FDA thinks about ARIA-E. Just goes to show you how interested the market is in AD and I think will bode for Prana in the near future.
That's what I mean....mms looking to pick off shares ...especially with tight stops or any stops at all.
Once volume slows down they move the price down to catch the stops.
Sentiment: Strong Buy